“Appendix 3B, New issue announcement, application for quotation of additional securities and agreement” of 6th June, 2018, is posted.
View and download Appendix 3B, New issue announcement, application for quotation of additional securities and agreement of 6th June, 2018.
Imagion Initiates Manufacturing of MagSense® Drug for Phase 2 Clinical Study on HER2+ Breast Cancer
MELBOURNE – Imagion Biosystems (Company) (ASX : IBX), a company dedicated to improving healthcare outcomes through the early detection of cancer, is pleased to announce